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Features

Our hyper-polarizing story:
understanding ATP-mediated vasodilatation in humans
Negative results, cynicism, the piecing together of puzzles and integrating
physiology with experimental approaches. It’s all part of the inspiring and
meandering journey on the path to understand ATP-mediated vasodilatation.

Anne Crecelius
University of Dayton, USA

Frank Dinenno
Colorado State University, USA

While it is satisfying to be ‘right’ as scientists, we know sometimes the
most important progress occurs when data are surprising or contrary to
our original hypothesis. The pursuit of explanations for unexpected findings
often leads to the best advancements. The story of how our laboratory
came to investigate the underlying vasodilator pathways of adenosine
triphosphate (ATP) (Crecelius et al. 2012) is an example of such a path to
our current understanding.
Regulation of vascular tone and the
endothelium
Since the early 20th century, physiologists
have been interested in skeletal muscle blood
flow regulation, particularly during occasions
of stress to the body, such as muscle
contraction (exercise) or changes in
gravitational force (standing). Eventually it
was realized the endothelium, a monolayer of
epithelial cells separating the lumen of the
vessel from the smooth muscle cells, was an
important mediator of vascular tone and
capable of releasing factors that elicited
vasodilatation. Robert F. Furchgott first posed
the idea of an ‘endothelium-derived relaxing
factor’ (EDRF) (Furchgott & Zawadzki, 1980),
later identified by Furchgott and Louis J.
Ignarro as the gaseous nitric oxide (NO).
In 1998, a Nobel Prize was awarded for the
discoveries concerning NO as a cardiovascular
signalling molecule. We and others were aware
of the potential relationship between NO and
cardiovascular health, particularly as it related
to ageing. Initially, we focused on the impact
of age and regular aerobic exercise training on
large artery structure and function, conduit
and resistance vessel endothelial function, and
peripheral blood flow under resting conditions.
Many of these studies did not address NO
specifically; however, bioavailability of this
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molecule, either attenuated with age or
improved with exercise, was a proposed
mechanism to a number of our observations.
Eventually, we used intra-arterial pharmacology
to address mechanisms of local regulation of
vascular tone and performed a variety of
studies, many to determine the role of NO by
utilizing exogenous L-arginine analogues (the
precursor for endothelial nitric oxide synthase
(NOS)-derived NO) to inhibit NO synthesis.
We also possessed the ability to directly
stimulate and inhibit the action of the
sympathetic nervous system with specific
receptor agonist and antagonists, fuelling our
rapid growth of understanding how the nervous
system influences skeletal muscle blood flow.
As the new millennium was ushered in, the
phenomenon of ‘functional sympatholysis’ (see
box), first proposed by Remensmyder in the
early 1960s (Remensnyder et al. 1962), was
observable in both human and animal studies in
a variety of preparations. Regarding underlying
mechanisms of this response, Thomas and
colleagues demonstrated that functional
sympatholysis in the contracting rat hindlimb
was impaired in the presence of NOS inhibition
(Thomas & Victor, 1998). However, when we
attempted to translate these findings of a
significant role for NO in functional
sympatholysis to our human studies, we were

What is ‘functional
sympatholysis’?
• Activation of the sympathetic
nervous system elicits
vasoconstriction via noradrenaline
(NA) binding to post-junctional
α-adrenergic receptors on vascular
smooth muscle cells.
Figure 1. ATP is sympatholytic in the human leg. In young healthy humans, leg blood flow
was measured at rest, during a hyperaemic steady-state and with femoral artery infusion of
tyramine to elicit endogenous noradrenaline release and therefore sympathetically mediated
vasoconstriction. Adenosine (cross-hatched bar) is used to cause significant vasodilatation
and increase blood flow to inactive tissue. Tyramine infusion results in significant
sympathetically mediated vasoconstriction during adenosine infusion but not during exogenous
ATP infusion (filled bars) or single leg-extension exercise (hatched bars). Data are means ±
SEM for 8 subjects. *P < 0.05 vs. high flow; †P < 0.05 vs. both combined ATP and tyramine
and exercise and tyramine. Modified from Rosenmeier et al. (2004) with permission.

unable to do so. We took a variety of
approaches, but continually failed to observe a
significant ability for NO to blunt sympathetically
mediated vasoconstriction when given directly
as sodium nitroprusside, as well as observed
intact functional sympatholysis in the presence
of NOS inhibition (Dinenno & Joyner, 2003).
Additionally, NO did not appear to be obligatory
for vasodilatation during muscle contractions
and combined inhibition of NO and other
endothelial-derived vasodilators such as
prostaglandins (PGs) resulted in a modest
decline (~25%) in exercise hyperaemia when
inhibition occurred during muscle contractions
(Schrage et al. 2004). Taken together, while
evidence was strong for the vasoprotective
properties of NO in humans, data from our
laboratory and others indicated that vascular
regulation during muscle contractions
appeared to be somewhat independent of this
endothelial-derived vasorelaxant.
Interestingly, the lack of an obligatory role for
NO in both exercise hyperaemia and functional
sympatholysis in humans was somewhat
perplexing given our findings demonstrating
impaired vasodilatation and functional
sympatholysis in healthy, sedentary older
individuals during exercise, a group wellcharacterized by decreased NO bioavailability
(Kirby et al. 2010, 2011). Had we observed
that NO was obligatory in these cases, a

logical theory of impaired blood flow control
during exercise in older adults would have
existed. This was not the case, and it would
take us several more years of both basic science
and clinical studies before we formed an overall
hypothesis for what molecule other than NO
might explain these collective findings.

Extracellular ATP: unique vascular
capabilities

• Functional sympatholysis describes
the ability of muscle contractions
to blunt the magnitude of
vasoconstriction that a given
sympathetic stimulus elicits,
relative to what occurs in inactive
tissue.
• This mechanism of vascular control
during exercise is thought to allow
for a balance between increased
local blood flow and therefore
oxygen delivery to active tissue,
while the ability to cause some
sympathetically mediated
vasoconstriction can occur to
prevent unopposed declines in
systemic resistance and therefore
maintain mean arterial blood
pressure.

Early studies appreciated the diverse function
of purines in cardiovascular regulation, but it
was not until the late 1990s that investigators
began to develop a hypothesis regarding the
role of erythrocyte-released extracellular ATP
as a mediator of the matching of muscle
perfusion to oxygen demand (Ellsworth et al.
2009). Building upon this idea, in 2004
Rosenmeier and colleagues demonstrated that
circulating ATP was capable of overriding
sympathetic vasoconstriction in the leg
evoked by the infusion of tyramine, a drug
that elicits endogenous noradrenaline (NA)
release (Fig. 1) (Rosenmeier et al. 2004). The
finding of an exogenous substance capable of
being ‘sympatholytic’ was rather surprising as
over the years we had tested many
substances in this regard, none of which
mimicked what occurred in contracting
skeletal muscle.
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Figure 2.

Figure 2. Summary of endothelial-derived hyperpolarization and pharmacological inhibition of inwardly rectifying potassium
channels (KIR) and Na+/K+-ATPase. ATP binds to purinergic type 2 receptors (P2R) causing endothelial intracellular [Ca2+] to
increase, stimulating calcium-activated potassium channels of small (sKCa) and intermediate (iKCa) conductance as well as
hyperpolarization of endothelial cells. K+ efflux from the KCa channels stimulates inwardly rectifying potassium (KIR) channels and
the Na+/K+-ATPase pump, both of which lead to membrane potential hyperpolarization and relaxation of the vascular smooth
muscle cells (VSMCs). Barium chloride (BaCl2) and ouabain can be used to inhibit KIR channels and Na+/K+-ATPase, respectively. KIR
channels are also activated directly by VSMC hyperpolarization and are thus thought to contribute to the amplification (Jantzi et
al. 2006) and spread of hyperpolarizing stimuli throughout the VSMC. VGCC, voltage-gated Ca2+ channel.

Figure 3. ATP-mediated
vasodilatation occurs through
activation of KIR channels. In young
healthy humans, forearm blood flow
was determined and forearm
vascular conductance (FVC) was
calculated (index of vascular tone)
at rest and during increasing doses
of exogenous ATP infusions
(brachial artery) in control
conditions (filled bars) and with
coinfusion of BaCl2 (cross-hatched
bars) to inhibit KIR channel
activation. The increase in FVC was
attenuated ~50% at both doses of
ATP. Data are means ± SEM for 6
subjects. *P < 0.05 vs. Control.
Modified from Crecelius et al.
(2012).
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In truth, we were quite sceptical of these
intriguing findings, and thus we designed a
study in the forearm to confirm ATP was
capable of overriding sympathetically
mediated vasoconstriction and specifically
address whether this occurred postjunctionally, as is the case during muscle
contractions. The synaptic level of modulation
was unable to be determined from the findings
of Rosenmeier and colleagues given their
experimental approach of tyramine-induced
vasoconstriction. To our surprise, we built
upon the results from the Scandinavian group
and showed ATP is clearly capable of postjunctional modulation of sympathetically
mediated vasoconstriction and importantly,
that this occurs in a graded manner such that
a low dose of exogenous ATP is not
sympatholytic, whereas higher doses are
(Kirby et al. 2008). The graded nature of the
sympatholytic ability of ATP parallels the
graded effect of exercise intensity on
functional sympatholysis. We were then
convinced that in addition to being a potent
vasodilator, ATP possesses unique signalling
properties that merit additional study.
At this time our interest in ageing began to
merge with our developing knowledge of
vasoactive ATP. Animal-based experiments
indicated that ATP-mediated vasodilatation
was dependent on an intact endothelium and
this led us to pursue whether ATP could be
used as a test of endothelial function in older
adults, similar to how the muscarinic agonist
acetylcholine was used by our group and
others. However, contrary to our hypothesis,
ATP-mediated vasodilatation was not impaired
in older individuals, despite these subjects
demonstrating ‘endothelial dysfunction’ as
characterized by impaired dilator responses to
acetylcholine (Kirby et al. 2010). This
‘incorrect’ hypothesis would be critical in the
development of our future research that tried
to explain this unanticipated finding. Firstly,
what endothelial-derived vasodilators was ATP
stimulating? Secondly, whatever this
mechanism might be, could it lend important
insight into the unexplained aspects of
vascular regulation during exercise?
Several lines of evidence suggested that what
was termed ‘endothelial dysfunction’ at that
point could be more specifically termed
‘decreased NO bioavailability’. Given ATP
seemed to be dissociated from NO
bioavailability based on our dilatory study in
older adults (Kirby et al. 2010) and the
studies on sympatholysis in younger adults
(Kirby et al. 2008), we pursued what
vasodilator pathways were stimulated by
exogenous ATP. Initially, we investigated the
role of the endothelial-derived vasodilators
NO and PGs, as the existing literature was
equivocal in this regard. No matter the manner
in which we tested the idea, at varied doses
and timing of inhibition and multiple
measurement techniques of muscle blood
flow, we were unable to inhibit ATP-mediated

vasodilatation more than ~20–30% (Crecelius
et al. 2011). We were left to consider the
non-NO, non-PG mechanisms of
endothelium-dependent vasodilatation.

Endothelial-derived hyperpolarization:
factoring it in
Upon closer examination of the literature from
animal models and isolated vessel
preparations, we began to appreciate that
non-NO, non-PG mechanisms of
vasodilatation were likely to be critical for
vascular control at rest and in response to
stimulation. However, similar to the original
unknown nature of NO and generalized name
of EDRF, these pathways were not well
described and generally termed endothelialderived hyperpolarizing factors (EDHFs); a
response dependent on the endothelium that
caused a characteristic hyperpolarization
(decrease in membrane potential) of
endothelial and vascular smooth muscle cells
leading to vasodilatation (Feletou & Vanhoutte,
2007). One hypothesis proposed potassium
(K+) could be an EDHF given its potential
release from endothelial cells and ability to
stimulate the Na+/K+-ATPase pump and
inwardly rectifying potassium channels (KIR) on
vascular smooth muscles causing membrane
potential hyperpolarization and vasorelaxation
(Edwards et al. 1998). An important aspect of
the proposed mechanism for K+ was its efflux
through calcium-activated K+ channels (KCa).
Taken together with data that demonstrated
inhibition of small- and intermediateconductance KCa channels essentially abolished
vasodilatation to luminal ATP application in the
rat mesentery (Edwards et al. 1998), we had
even more motivation to try and address
hyperpolarizing mechanisms of vasodilatation
in our human model as it might lend insight to
our previous findings regarding ATP.

“It is often challenging
to translate mechanistic
findings from animal
models and in vitro
studies to our human
model, given our
concerns for human
safety.”

To date, investigators interested in inhibiting
vascular hyperpolarization in humans were
somewhat limited in the pharmacology that
could be safely administered to do so. The
toxins and venoms often used in isolated vessel
preparations to inhibit small- and
intermediated-conductance KCa channels posed
safety risks. Enzymatic inhibition of specific
proposed stimuli of hyperpolarization (e.g.
cytochrome p450, H2O2, etc.) left readers
questioning efficacy since directly challenging
these inhibitors was difficult. We were excited
to find that barium chloride (BaCl2) and ouabain
could be given intra-arterially in low doses to
inhibit KIR channels and Na+/K+-ATPase,
respectively (Dawes et al. 2002). Importantly,
low doses of KCl could be given intra-brachially
to cause hyperpolarization and directly
challenge inhibitor efficacy (Fig. 2). We saw an
exciting opportunity to try and translate the
isolated vessel experiments that supported a
role for hyperpolarization in ATP-mediated
vasodilatation (Winter & Dora, 2007) by
inhibiting downstream mechanisms of VSMC
hyperpolarization (Edwards et al. 1998).
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Figure 4. Older adults fail to increase plasma [ATP] during handgrip exercise. Young (dark bars; 18–35 years) and older (light
bars; 60–85 years) healthy individuals performed rhythmic handgrip exercise for 5 min at each increasing intensity (percent of
individual maximal voluntary contraction (MVC)). Forearm blood flow (FBF) was measured and venous plasma [ATP] was
determined via luciferin–luciferase assay of samples obtained from a retrograde antecubital catheter in the exercising arm. A,
FBF was attenuated in older adults at 15% and 25% MVC. B, young individuals significantly increased [ATP]v at all exercise
intensities, whereas older individuals failed to increase [ATP]v during exercise. At all intensities, [ATP]v was lower in older
individuals than the young adults. *P < 0.05 vs. rest; †P < 0.05 vs. young adults. ‡P < 0.05 vs. 5% and 15% MVC within young
adults. FFM, fat-free mass. Modified from Kirby et al. (2012).

Figure 5. Relationship of ATP, ageing and the regulation of vascular tone during exercise in humans. Exercise stimulates significant
local vasodilatation and at sufficient intensity can activate the sympathetic nervous system to cause sympathetic
vasoconstriction. The blunting of sympathetically mediated vasoconstriction that occurs in active skeletal muscle during exercise
is known as ‘functional sympatholysis’. Older individuals display attenuated exercise vasodilatation and impaired functional
sympatholysis (Dinenno et al. 2005; Kirby et al. 2011), yet the underlying mechanisms are not well understood. We have recently
shown that ATP signals vasodilatation (1) primarily through KIR channel activation (Crecelius et al. 2012) and unlike other
exogenous vasodilators, ATP is capable of modulating sympathetic vasoconstriction (2) and this occurs in a graded fashion, similar
to during exercise (Kirby et al. 2008). Interestingly, the dilatory responsiveness to ATP (1) as well as the sympatholytic ability of
this purine (2) is preserved in older individuals. Exercise elicits significant increases in venous plasma [ATP] in young individuals (3);
however, this does not occur in older adults (Kirby et al. 2012). Thus, we propose impaired functional sympatholysis in this
population may be due in part to the inability to release sufficient concentrations of ATP to signal endothelium-dependent
hyperpolarization.
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The ‘wow’ moment
It was necessary to first establish our ability to
sufficiently inhibit a hyperpolarizing stimulus
(exogenous KCl) with the combination of BaCl2
and ouabain, as had previously been described
(Dawes et al. 2002). With these control
experiments completed (in fairly profound
fashion as we essentially eliminated any
K+-mediated vasodilatation), we began our
first experiments to test the impact of
inhibition of KIR channels and Na+/K+-ATPase
on ATP-mediated vasodilatation (Crecelius et
al. 2012). These first studies were some of
the more exciting in the laboratory to date.
Given our data are collected in real-time, we
were able to immediately estimate the changes
in muscle blood flow following inhibition. From
the first subject forward, it was clear these
inhibitors were more ‘powerful’ than those we
had used before and a large portion of
ATP-mediated vasodilatation was explained by
these pathways. After a number of experimental
approaches, we determined the primary
mechanism of ATP-mediated vasodilatation is
vascular hyperpolarization via activation of KIR
channels (Fig. 3) (Crecelius et al. 2012).

Putting it all together
As we were working to understand the basic
signalling mechanisms of ATP, we were
concurrently studying the potential role for
ATP in the control of vascular tone during
exercise in young and older adults, given the
finding in young subjects that in sufficient
concentration, it was sympatholytic
(Rosenmeier et al. 2004; Kirby et al. 2008).
Interestingly, although not completely
surprising given our emerging overall working

hypothesis, we demonstrated ATP was capable
of blunting direct sympathetically mediated
vasoconstriction in older individuals, despite
these individuals having impaired exerciseinduced functional sympatholysis (Kirby et al.
2011). Had we dissociated ATP and
sympatholysis with these findings? Or, was it
possible ATP retained the same vascular
signalling capabilities in older adults, but this
population failed to increase ATP during exercise
to the same concentration as young individuals?
We had begun to make plasma measures of
ATP in the laboratory and pursued this
hypothesis to tie our multiple studies together.
This time, our ageing hypothesis was ‘correct’
as we showed older individuals failed to
increase plasma ATP during incremental
handgrip exercise in contrast to the significant
increase observed in younger individuals (Fig.
4) (Kirby et al. 2012). Thus, while we
admittedly have not been able to directly
inhibit the purinergic receptors to which ATP
binds, as no pharmacology has been established
that is capable of doing so, our findings of the
mechanisms for ATP-mediated vasodilatation
and our ageing data continue to support our
overall hypothesis regarding a role for ATP in
muscle blood flow regulation during exercise
(Fig. 5).

“In truth, we were quite
sceptical of these
intriguing findings, and
thus we designed a
study in the forearm to
confirm ATP was
capable of overriding
sympathetically
mediated
vasoconstriction…”

Along the way
The ability to inhibit KIR channels and Na+/
K+-ATPase has provided the laboratory with a
powerful pharmacological tool that we
continue to use to address a number of
hypotheses. Armstrong and colleagues had
demonstrated a role of K+-mediated
vasodilatation in rapid vasodilatation following
a single muscle contraction in the hamster

Figure 6. Reactive hyperaemia occurs via activation of KIR channels and Na+/K+-ATPase. In young healthy humans, inhibition of KIR
channels via barium chloride (BaCl2) significantly attenuates both the peak (A) and total (area under 150 s curve) (B) reactive
hyperaemia (RH) following 5 min of forearm ischaemia (via upper arm cuff arterial occlusion). Inhibition of Na+/K+-ATPase via
ouabain has no impact on peak RH (A) whereas results in a significant attenuation of total RH (B) and when combined with BaCl2,
nearly abolishes the response. Data are means ± SEM for 8 and 16 subjects (BaCl2 or ouabain and BaCl2+ouabain, respectively). *P
< 0.05 vs. zero; †P < 0.05 vs. BaCl2. ‡P < 0.05 vs. ouabain. Modified from Crecelius et al. (2013b).
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cremaster (Armstrong et al. 2007) using BaCl2
and ouabain along with a pharmacological
inhibitor of K+ efflux from skeletal muscle.
Given our interest in rapid vasodilatation and
the minimal number of mechanistic studies on
the topic (Kirby et al. 2007), attempting to
translate the findings of Armstrong and
colleagues seemed prudent. In general, in line
with the findings in the animal model, we
demonstrated a significant role for K+ in
mediating a portion of rapid vasodilatation in
response to a single muscle contraction at a
variety of intensities (Crecelius et al. 2013a).
Of perhaps greater clinical relevance, we
recently determined whether reactive
hyperaemia (RH), the large increase in blood
flow following release of temporary ischaemia
of skeletal muscle, was mediated by KIR
channels and Na+/K+-ATPase. Although RH is a
useful test of microvascular function and has
clinical value in assessing risk of cardiovascular
health (Anderson et al. 2011), prior to our
work the underlying signalling mechanisms
were largely undetermined. Impressively, nearly
all (~90%) of the total (area under the curve)
RH can be explained by combined activation of
KIR channels and Na+/K+-ATPase and ~50% of
the peak response is due to KIR channel
activation (Fig. 6) (Crecelius et al. 2013b). This
magnitude of inhibition is by far the most
profound that has been observed to date.

Moving forward
We continue to pursue our ideas regarding
muscle blood flow regulation, specifically
during exercise and the unique role ATP may
have in modulating sympathetic
vasoconstriction. It is often challenging to
translate mechanistic findings from animal
models and in vitro studies to our human
model, given our concerns for human safety.
Part of what we find inspiring from this story is
the integration of physiology and experimental
approaches that was required to reach the
point we find ourselves at. We drew from
findings in older individuals to guide our basic
science studies as well as applying our findings
from young healthy humans to older
individuals. While we probably would not have
pursued many of these ideas without the initial
findings and discoveries related to NO, we have
developed a cautious attitude towards
‘endothelial function’ as we have seen
first-hand this monolayer is far more involved
in vascular regulation than simply being a
source of NO. Similarly, mechanistic studies in
vitro and in animal models continue to
stimulate ideas and provide rationale; yet, we
observe important differences when
translating some of these approaches to
humans. Importantly, we acknowledge that
scepticism, negative findings and unsupported
hypotheses have provided us important
directions we have excitedly followed.
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